Jacqueline Lobsiger, APRN
Primary Care · Salt Lake City, UTNPI 1497774525
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $404 and has fallen 71.4% since, to $115 in 2025.
Across 68 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$201
- Abbott$197
- AbbVie$82
- Pfizer$74
- Novo Nordisk$74
- Merck$71
- plus $611 from 20 others
What the payments were for
- Food & beverage$1,310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 12 | $201 |
| Abbott | 9 | $197 |
| AbbVie | 4 | $82 |
| Pfizer | 4 | $74 |
| Novo Nordisk | 4 | $74 |
| Merck | 4 | $71 |
| GSK | 4 | $62 |
| Astellas Pharma US Inc | 3 | $61 |
| Amgen | 3 | $58 |
| Irhythm Technologies, Inc. | 2 | $54 |
| Novartis | 2 | $38 |
| RGH Enterprises LLC | 1 | $38 |
| Mylan Specialty L.p. | 2 | $37 |
| Corcept Therapeutics | 1 | $36 |
| Bayer | 2 | $35 |
| Exact Sciences | 1 | $24 |
| Recor Medical Inc | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Grifols USA, LLC | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Banner Life Sciences, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Sumitomo Pharma America, Inc. | 1 | $3 |
How this compares
$1,310 in reported general payments places this provider in the 70th percentile of 60 primary care providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $35,404 |
| JardianceEmpagliflozin | 25 | $27,732 |
| OzempicSemaglutide | 15 | $14,481 |
| Spiriva RespimatTiotropium Bromide | 14 | $11,366 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $6,095 |
| MyrbetriqMirabegron | 12 | $5,949 |
| Omeprazole | 89 | $1,301 |
| Levothyroxine Sodium | 84 | $1,209 |
| Atorvastatin Calcium | 128 | $1,179 |
| SynthroidLevothyroxine Sodium | 14 | $1,019 |
| Losartan Potassium | 81 | $857 |
| Fluoxetine Hcl | 41 | $752 |
| Bupropion Hcl SrBupropion Hcl | 11 | $639 |
| Duloxetine Hcl | 21 | $612 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $74 | $35,40435 claims |
| Novo NordiskOzempic | $74 | $14,48115 claims |
| GSKBreo Ellipta | $62 | $6,09511 claims |
| Astellas Pharma US IncMyrbetriq | $61 | $5,94912 claims |
| AbbVieSynthroid | $82 | $1,01914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 60 primary care providers in Utah.
Other primary care in Salt Lake City
- Catherine CoatesSalt Lake City$5K
- Madeleine RupertSalt Lake City$3K
- Megan KalraSalt Lake City$878
- Margaret GroganSalt Lake City$694
- Kristie ChristensenSalt Lake City$535
- Jennifer McCulloughSalt Lake City$295
- Matthew AndersonSalt Lake City$126
- Dayne TattersallSalt Lake City$88
- Suzanne TalkenSalt Lake City$38
- James ViskerSalt Lake City$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.